Back
Axsome Therapeutics Stock Price Chart
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35
AXSM
Axsome Therapeutics
Last Price:
$109.95
Seasonality Move:
19.74%
7 Day Trial
ALL ACCESS PASS
$
7
AI Is Disrupting Marketing—Invest Before April 10!
⏳ Secure Your Stake in AI Marketing Before This Window Closes!-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing slight buying pressure.
Axsome Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 120.51 | Sell |
| 20-day SMA: | 122.32 | Sell |
| 50-day SMA: | 118.5 | Sell |
| 200-day SMA: | 95.68 | Buy |
| 8-day EMA: | 118.83 | Sell |
| 20-day EMA: | 121.23 | Sell |
| 50-day EMA: | 116.96 | Sell |
| 200-day EMA: | 99.27 | Buy |
Axsome Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.72 | Sell |
| Relative Strength Index (14 RSI): | 36.05 | Sell |
| Chaikin Money Flow: | 647254 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (119.19 - 127.47) | Sell |
| Bollinger Bands (100): | (89.52 - 121.2) | Buy |
Axsome Therapeutics Technical Analysis
| Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Axsome Therapeutics Stock
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 111.67 while AXSM 8-day simple moving average is 120.51, which is a Sell signal.
-
The stock price of AXSM is 111.67 while Axsome Therapeutics 20-day SMA is 122.32, which makes it a Sell.
-
Axsome Therapeutics 50-day simple moving average is 118.50 while AXSM share price is 111.67, making it a Sell technically.
-
AXSM stock price is 111.67 and Axsome Therapeutics 200-day simple moving average is 95.68, creating a Buy signal.
AXSM Technical Analysis vs Fundamental Analysis
Sell
35
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy or a Sell?
-
Axsome Therapeutics stock is rated a SellThe current Axsome Therapeutics [AXSM] share price is $111.67. The Score for AXSM is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Axsome Therapeutics Stock Info
Market Cap:
5.4B
Price in USD:
111.67
Share Volume:
1.7M
Axsome Therapeutics 52-Week Range
52-Week High:
139.13
52-Week Low:
64.11
Sell
35
Axsome Therapeutics (AXSM)
is a Sell
Axsome Therapeutics Share Price Forecast
-
What is the Axsome Therapeutics stock price today?The Axsome Therapeutics stock price is 111.67 USD today.
-
Will AXSM stock go up or go down?Axsome Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Axsome Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Axsome Therapeutics is overvalued.
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 111.67 while AXSM 8-day exponential moving average is 118.83, which is a Sell signal.
-
The stock price of AXSM is 111.67 while Axsome Therapeutics 20-day EMA is 121.23, which makes it a Sell.
-
Axsome Therapeutics 50-day exponential moving average is 116.96 while AXSM share price is 111.67, making it a Sell technically.
-
AXSM stock price is 111.67 and Axsome Therapeutics 200-day simple moving average is 99.27, creating a Buy signal.
Fundamental Analysis of Axsome Therapeutics
Is Axsome Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $1.82 per share, and an increase next year of $4.87 per share.
Technical Analysis of Axsome Therapeutics
Should I short Axsome Therapeutics stock?
-
AXSM Moving Average Covergence Divergence (MACD) indicator is -0.73, suggesting Axsome Therapeutics is a Sell
-
Axsome Therapeutics Relative Strength Index (RSI) is 36.05, which suggest Axsome Therapeutics is oversold
-
The Bollinger Bands (25) for Axsome Therapeutics is (119.19 - 127.47), which suggest Axsome Therapeutics is a Buy
-
The Bollinger Bands (100) for Axsome Therapeutics is (89.52 - 121.2), which suggest Axsome Therapeutics is a Buy
* Axsome Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.